Please provide your email address to receive an email when new articles are posted on . A recent study found that time-restricted eating was associated with a reduced risk for CVD among older women ...

Please provide your email address to receive an email when new articles are posted on . Researchers estimated that the lifetime benefit of smoking cessation on major cardiovascular events was similar ...

Screening, early treatment, and personalized therapy for atrial fibrillation are on the agenda of an international meeting starting today. The 8th joint consensus conference of the German Atrial ...

Irregular heart rhythms, such as atrial fibrillation and atrial flutter, affect millions of Americans and can increase the risk of serious complications if left untreated. Understanding the warning ...

More people have atrial fibrillation (AFib) than any other kind of irregular heartbeat. And the numbers are only expected to go up as people live longer with heart conditions that go along with it.

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for ...

The anticoagulant medication dabigatran yielded similar results to warfarin for the prevention of cognitive decline in older adults with atrial fibrillation after two years of treatment, according to ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Previously, patients with advanced atrial fibrillation (AF ...

Valvular atrial fibrillation (A-fib) involves a condition that leads to an irregular or abnormal heart rhythm. This can increase a person’s risk of cardiovascular complications, such as stroke.

VANCOUVER, British Columbia--(BUSINESS WIRE)--Kardium Inc., the developer of the Globe ® Pulsed Field System – an innovative treatment for atrial fibrillation (AF) – has raised US$250 million in a new ...